4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-19-042993
Options or other derivatives
- EVP, Chief Financial Officer acquired 400,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Shukla Sath EVP, Chief Financial Officer | 2019-07-22 | Grant or award · Employee Stock Option (Right to Buy) | +400,000 | 400,000 | D | ||
Loading xslF345X03/doc4.xml…